Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

被引：0

作者：

Cabibbo, G. ^{[1
]}

Cacciola, I. ^{[2
]}

Cannavo, M. R. ^{[3
]}

Madonia, S. ^{[4
]}

Calvaruso, V. ^{[5
]}

Petta, S. ^{[1
]}

Di Stefano, M. ^{[6
]}

Larocca, L. ^{[7
]}

Prestileo, T. ^{[8
]}

Tine, F. ^{[9
]}

Digiacomo, A. ^{[10
]}

Bertino, G. ^{[11
]}

Giannitrapani, L. ^{[12
]}

Benanti, F. ^{[13
]}

Davi, A. ^{[14
]}

Volpes, R. ^{[15
]}

Guarneri, L. ^{[16
]}

Averna, A. ^{[17
]}

Scalisi, I. ^{[18
]}

Iacobello, C. ^{[19
]}

Mazzola, G. ^{[20
]}

Cartabellotta, F. ^{[21
]}

Portelli, V. ^{[22
]}

Russello, M. ^{[23
]}

Scifo, G. ^{[24
]}

Squadrito, G. ^{[25
]}

Raimondo, G. ^{[25
]}

Craxi, A. ^{[1
]}

Di Marco, V. ^{[1
]}

Camma, C. ^{[1
]}

机构：

[1] Univ Palermo, Gastroenterol & Epatol, DIBIMIS, Palermo, Italy

[2] AOUP G Di Martino, Epatol Clin & Mol, Messina, Italy

[3] ARNAS Garibaldi Nesima, UOD Epatol, Catania, Italy

[4] AO Cervello Villa Sofia, Med Interna, Palermo, Italy

[5] Univ Palermo, Gastroenterol & Epatol, Palermo, Italy

[6] UmbertoIO, Malattie Infett, Siracusa, Italy

[7] AOUP Vittorio Emanuele, Malattie INfett, Catania, Italy

[8] ARNAS Civ Di Cristina Benefratelli, Malattie Infett, Palermo, Italy

[9] AO Cervello Villa Sofia, Gastroenterol, Palermo, Italy

[10] Presidio Osped, Med Interna, Comiso, Italy

[11] Vittorio Emanuele, Med Interna & Urgenza, Catania, Italy

[12] Univ Palermo, Med Interna, Palermo, Italy

[13] Garibaldi Nesima, Malattie Infett, Catania, Italy

[14] Presidio Osped Modica, Malattie Infett, Modica, Italy

[15] ISMETT, Palermo, Italy

[16] Umberto I, Malattie Infett, Enna, Italy

[17] S Elia, Malattie Infett, Caltanissetta, Italy

[18] Presidio Osped Castelvetrano, Med Interna, Trapani, Italy

[19] Cannizzaro, Malattie Infett, Catania, Italy

[20] Univ Palermo, Malattie Infett, Palermo, Italy

[21] Buccheri La Ferla, Med Interna, Palermo, Israel

[22] PO, Malattie Infett, Trapani, Israel

[23] Garibaldi, Gastroenterol, Catania, Italy

[24] Umberto I, Malattie Infett, Siracusa, Italy

[25] Univ Messina, Epatol Clin & Mol, Messina, Italy

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)30734-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-096

引用

页码：S218 / S218

页数：1

共 50 条

[31] Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma
Marrero, Jorge A.
Singal, Amit G.
LIVER TRANSPLANTATION, 2017, 23 (09) : 1099 - 1100
[32] Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
William M. Kamp
Cortlandt M. Sellers
Stacey Stein
Joseph K. Lim
Hyun S. Kim
Scientific Reports, 9
[33] Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
Kamp, William M.
Sellers, Cortlandt M.
Stein, Stacey
Lim, Joseph K.
Kim, Hyun S.
SCIENTIFIC REPORTS, 2019, 9 (1)
[34] Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
Chi, Chen-Ta
Chen, Chi-Yi
Su, Chien-Wei
Chen, Po-Yueh
Chu, Chi-Jen
Lan, Keng-Hsin
Lee, I-Cheng
Hou, Ming-Chih
Huang, Yi-Hsiang
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 385 - 395
[35] Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?
Ogawa, Masahiro
Kanda, Tatsuo
Moriyama, Mitsuhiko
HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (04) : 423 - 425
[36] Risk of hepatocellular carcinoma for patients treated with direct-acting antivirals: steps after hepatitis C virus eradication to achieve elimination
Lee, Mei-Hsuan
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
[37] A genetic risk score predicts de novo hepatocellular carcinoma in hepatitis C cirrotic patients treated with direct-acting antivirals
Degasperi, Elisabetta
Galmozzi, Enrico
Pelusi, Serena
D'ambrosio, Roberta
Soffredini, Roberta
Borghi, Marta
Perbellini, Riccardo
Facchetti, Floriana
Iavarone, Massimo
Sangiovanni, Angelo
Bruccoleri, Mariangela
Valenti, Luca
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2020, 73 : S208 - S209
[38] The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience
Bielen, R.
Moreno, C.
Van Vlierberghe, H.
Bourgeois, S.
Mulkay, J. -P.
Vanwolleghem, T.
Verlinden, W.
Brixco, C.
Decaestecker, J.
de Galocsy, C.
Janssens, F.
Van Overbeke, L.
Van Steenkiste, C.
D'Heygere, F.
Cool, M.
Wuyckens, K.
Nevens, F.
Robaeys, G.
JOURNAL OF VIRAL HEPATITIS, 2017, 24 (11) : 976 - 981
[39] Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus
Guardigni, Viola
Toschi, Alice
Badia, Lorenzo
Del Turco, Elena Rosselli
Salsi, Eleonora
Cristini, Francesco
Sighinolfi, Laura
Fabbri, Gabriele
Massari, Marco
Cuomo, Gianluca
Viale, Pierluigi
Verucchi, Gabriella
AIDS, 2021, 35 (12) : 1967 - 1972
[40] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
Ioanna Aggeletopoulou
Christos Konstantakis
Spilios Manolakopoulos
Christos Triantos
World Journal of Gastroenterology, 2017, (24) : 4317 - 4323

← 1 2 3 4 5 →